C4 Therapeutics (C4T) is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.
View all
Corvus Pharmaceuticals
Burlingame, United States · Post IPO Equity
Magenta Therapeutics
Cambridge, United States · Post IPO Equity
Nabriva Therapeutics
King of Prussia, United States · Post IPO Equity
Stemline Therapeutics
New York, United States · Post IPO Equity
Krystal Biotech
Pittsburgh, United States · Post IPO Equity
Axsome Therapeutics
New York, United States · Post IPO Equity
Ovid Therapeutics
New York, United States · Post IPO Equity
Jounce Therapeutics
Cambridge, United States · Post IPO Equity
Translate Bio
Lexington, United States · Post IPO Equity
Arbutus Biopharma
Warminster, United States · Post IPO Equity
Quince Therapeutics
South San Francisco, United States · Post IPO Equity
Sigilon Therapeutics
Cambridge, United States · Post IPO Equity